SynthesisOpen heart2026

Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis.

Li Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.